STX2 and hemolytic-uremic syndrome: We further analyzed the RNAseq data (GSE180476) from the mouse HUS model study (6 h post-treatment with LPS/Stx2) conducted by Kume et al. [23] to explore the chemoattractant involved in monocyte renal infiltration.